News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Ferro Corporation Reports 2008 Third-Quarter Results
November 6, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CLEVELAND--(BUSINESS WIRE)--Ferro Corporation (NYSE: FOE) (the “Company”) today announced net sales of $608.6 million for the quarter ended September 30, 2008, up 11 percent from net sales of $550.7 million in the third quarter of 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Collaboration
VantAI Links With Halda in Potential $1B+ Proteomics Pact
August 19, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech
August 18, 2025
·
1 min read
·
Dan Samorodnitsky
GLP-1
Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot
August 18, 2025
·
1 min read
·
Annalee Armstrong
Funding
Gene Therapy Specialist Kriya Raises $313M
August 18, 2025
·
2 min read
·
Tristan Manalac
